Literature DB >> 19880681

Chordoma of the sacrum and vertebral bodies.

Daniel M Sciubba1, Jennifer J Cheng, Rory J Petteys, Kristy L Weber, Deborah A Frassica, Ziya L Gokaslan.   

Abstract

Chordomas are relatively rare tumors of bone. These primary malignant lesions occur throughout the spinal column and often show advanced growth at the time of diagnosis. Because such tumors are minimally responsive to radiation and chemotherapy, surgical resection is the mainstay of treatment. Patient survival and local control are associated with the ability to achieve wide surgical margins during excision. However, surgical morbidity may be substantial given the propensity for chordomas to abut or surround neural, vascular, and visceral structures. Thus, early recognition is essential, and treatment by a multidisciplinary team is ideal.

Entities:  

Mesh:

Year:  2009        PMID: 19880681     DOI: 10.5435/00124635-200911000-00005

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  13 in total

1.  High expression of SPHK1 in sacral chordoma and association with patients' poor prognosis.

Authors:  Kai Zhang; Hao Chen; Guizhong Wu; Kangwu Chen; Huilin Yang
Journal:  Med Oncol       Date:  2014-09-27       Impact factor: 3.064

2.  Triple primary origin tumor: a case report.

Authors:  Yong-Su Jung; Se-Hoon Kim; Sung-Kon Ha; Sang-Dae Kim; Dong-Jun Lim
Journal:  Korean J Spine       Date:  2013-06-30

3.  Overexpression of Raf-1 and ERK1/2 in sacral chordoma and association with tumor recurrence.

Authors:  Kai Zhang; Hao Chen; Bin Zhang; Jiajia Sun; Jian Lu; Kangwu Chen; Huilin Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

4.  MicroRNA profiling and bioinformatics analyses reveal the potential roles of microRNAs in chordoma.

Authors:  Kangwu Chen; Hao Chen; Kai Zhang; Siwei Sun; Jianqiang Mo; Jian Lu; Zhonglai Qian; Huilin Yang
Journal:  Oncol Lett       Date:  2017-08-28       Impact factor: 2.967

5.  Expression of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in sacral chordoma.

Authors:  Ming Zhou; Kangwu Chen; Huilin Yang; Genlin Wang; Jian Lu; Yiming Ji; Chunshen Wu; Chao Chen
Journal:  J Neurooncol       Date:  2013-10-18       Impact factor: 4.130

6.  Chondromyxoid fibroma of the sacrum: A case report and literature review.

Authors:  Tanya Minasian; Chad Claus; Omid R Hariri; Zhe Piao; Syed A Quadri; Robert Yuhan; Darren Leong; Vartan Tashjian
Journal:  Surg Neurol Int       Date:  2016-05-17

7.  Characteristics and Patterns of Metastatic Disease from Chordoma.

Authors:  Victoria A Young; Kevin M Curtis; H Thomas Temple; Frank J Eismont; Thomas F DeLaney; Francis J Hornicek
Journal:  Sarcoma       Date:  2015-12-30

8.  Thoracic intramedullary chordoma without bone involvement: a rare clinical entity.

Authors:  Mohd Faheem; Qazi Zeeshan; Balkrishna Ojha; Preeti Agrawal
Journal:  BMJ Case Rep       Date:  2016-07-28

9.  Results following surgical resection of recurrent chordoma of the spine: experience in a single institution.

Authors:  Pongsthorn Chanplakorn; Thamrong Lertudomphonwanit; Wittawat Homcharoen; Prakrit Suwanpramote; Wichien Laohacharoensombat
Journal:  World J Surg Oncol       Date:  2020-08-27       Impact factor: 2.754

10.  Three-Dimensional Volume Imaging to Increase the Accuracy of Surgical Management in a Case of Recurrent Chordoma of the Clivus.

Authors:  João Pedro Perez Gomes; José de Ribamar Castro Veloso; Albina Messias de Almeida M Altemani; Carlos Takahiro Chone; João Mauricio Carrasco Altemani; Claudio Fróes de Freitas; Carmen Silvia Passos Lima; Paulo Henrique Braz-Silva; Andre Luiz Ferreira Costa
Journal:  Am J Case Rep       Date:  2018-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.